A 2-stage phase II design with direct assignment option in stage II for initial marker validation.
about
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewMolecular and clinical implementations of ovarian cancer mouse avatar modelsFrom bench to bedside: lessons learned in translating preclinical studies in cancer drug developmentExploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignment.Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicine.The direct assignment option as a modular design component: an example for the setting of two predefined subgroupsClinical trial designs incorporating predictive biomarkers.A review of phase II trial designs for initial marker validation.Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.The role of adaptive trial designs in drug development.Adaptive randomized phase II design for biomarker threshold selection and independent evaluation.
P2860
Q26766584-A44C99B4-A68F-43E4-9E66-E162245A6A6CQ26786724-BA01EA5B-1D83-49F0-B006-979DEFC139F8Q28533949-887CEE2F-FECD-4020-B103-C8EBB511934DQ33923067-70EF2F27-BEFE-4D09-A337-B35EA90713D7Q34535243-BDA919A0-8CF1-4BBD-A467-4F4A99BCF0F1Q35026541-2EC42332-94C4-4420-A638-A31DF3DA456EQ36534713-AC798E07-429C-4A26-9E23-E490F05CDA07Q37188715-F51EA5A8-1E2D-412E-96C3-E6EAF847F6CEQ37731264-F201DF0D-8B4A-49FC-98FC-F3CAD68BC44CQ38691922-55936092-75BF-4E4F-8B93-F4556B7FE4ADQ43055307-EC7F9A97-DE30-4A5C-B80E-C1FF070F5F25
P2860
A 2-stage phase II design with direct assignment option in stage II for initial marker validation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A 2-stage phase II design with ...... for initial marker validation.
@ast
A 2-stage phase II design with ...... for initial marker validation.
@en
type
label
A 2-stage phase II design with ...... for initial marker validation.
@ast
A 2-stage phase II design with ...... for initial marker validation.
@en
prefLabel
A 2-stage phase II design with ...... for initial marker validation.
@ast
A 2-stage phase II design with ...... for initial marker validation.
@en
P2093
P2860
P1476
A 2-stage phase II design with ...... for initial marker validation.
@en
P2093
Daniel J Sargent
Ming-Wen An
Sumithra J Mandrekar
P2860
P304
P356
10.1158/1078-0432.CCR-12-0686
P407
P577
2012-06-14T00:00:00Z